| 1 中国医师协会急诊医师分会. 中国急诊高血压管理专家共识[J]. 中国急救医学, 2010, 30:865-876.2 中国高血压防治指南修订委员会. 中国高血压指南2010[J]. 中华高血压杂志, 2010, 19:701-743.3 Varon J. Treatment of acute severe hypertension:current and newer agents[J]. Drugs, 2008, 68:283-297.4 Saguner AM, Dur S, Perrig M, et al. Risk factors promoting hypertensive crises:evidence from a longitudinal study[J]. Am J Hypertens, 2010, 23:775-780.5 Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension:the Studying the Treatment of Acute hyperTension (STAT) registry[J]. Am Heart J, 2009, 158:599-606.6 Tisdale JE, Huang MB, Borzak S. Risk factors for hypertensive crisis:importance of out-patient blood pressure control[J]. Fam Pract, 2004, 21:420-424.7 Espinel E, Tovar JL, Borrellas J, et al. Angiotensin-converting enzyme i/d polymorphism in patients with malignant hypertension[J]. J Clin Hypertens, 2005, 7:11-15.8 Marik PE, Varon J. Hypertensive crises challenges and management[J]. Chest, 2007, 131:1949-1962.9 Lassegue B, Griendling KK. Reactive oxygen species in hypertension:an update[J]. Am J Hypertens, 2004, 17:852-860.10 The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH/ESC Guidelines for the management of arterial hypertension[J]. J Hypertens, 2013, 31:1281-1357.11 Faraci FM, Heistad DD. Regulation of cerebral blood vessels by humoral and endothelium-dependent mechanisms. Update on humoral regulation of vascular tone[J]. Hypertension, 1991, 17:917-922.12 Melo RO, Martin JF, Toledo JC, et al. Acute aortic dissection associated with hypertensive emergency[J]. Rev Bras Cir Cardiovasc, 2008, 23:586-588.13 Wityk RJ. The management of blood pressure after stroke[J]. Neurologist, 2007, 13:171-181.14 Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS):a randomised, placebo-controlled, double-blind pilot trial[J]. Lancet Neurol, 2009, 8:48-56.15 Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST):a randomised, placebo-controlled, double-blind trial[J]. Lancet, 2011, 377:741-750.16 Rodriguez G, Varon J. Clevidipine:a unique agent for the critical care practitioner[J]. Crit Care Shock, 2006, 9:9-15. 17 Bailey JM, Lu W, Levy JH, et al. Clevidipine in adult cardiac surgical patients:a dose-finding study[J]. Anesthesiology, 2002, 96:1086-1094.18 Segawa D, Sjoquist PO, Wang QD, et al. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts. Part II[J]. J Cardiovasc Pharmacol, 2002, 40:339-345.19 Stephens CT, Jandhyala BS. Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats[J]. Clin Exp Hypertens, 2002, 24:301-313.20 Pollack CV, Varon J, Garrison NA, et al. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension[J]. Ann Emerg Med, 2009, 53:329-338.21 Levy JH, Mancao MY, Gitter R, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients:the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1[J]. Anesth Analg, 2007, 105:918-925.22 Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute postoperative hypertension in cardiac surgery patients:an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial[J]. Anesth Analg, 2008, 107:59-67. |
